Cytosorbents Corporation
CTSO
$1.10
-$0.06-5.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.72M | -19.41M | -26.27M | -28.28M | -29.25M |
| Total Depreciation and Amortization | 1.74M | 2.11M | 2.14M | 2.15M | 2.02M |
| Total Amortization of Deferred Charges | 380.80K | 190.40K | 0.00 | 0.00 | 0.00 |
| Total Other Non-Cash Items | 8.54M | 1.12M | 6.49M | 4.82M | 2.92M |
| Change in Net Operating Assets | -4.38M | -2.50M | -3.61M | -2.07M | 2.65M |
| Cash from Operations | -14.43M | -18.49M | -21.24M | -23.38M | -21.66M |
| Capital Expenditure | -284.30K | -310.60K | -301.30K | -73.70K | -538.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -385.00K | -370.40K | -339.10K | -306.70K | -398.10K |
| Cash from Investing | -669.50K | -681.20K | -640.50K | -380.30K | -936.20K |
| Total Debt Issued | 15.00M | 15.00M | 15.00M | -- | -- |
| Total Debt Repaid | -5.00M | -5.00M | -5.00M | -625.00K | -- |
| Issuance of Common Stock | 220.10K | 12.26M | 12.91M | 13.84M | 14.47M |
| Repurchase of Common Stock | -41.50K | -41.50K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -848.00K | -848.00K | -790.40K | -- | -- |
| Cash from Financing | 9.33M | 21.37M | 22.12M | 13.22M | 14.47M |
| Foreign Exchange rate Adjustments | -84.70K | -77.40K | -139.50K | -104.70K | -99.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.85M | 2.12M | 103.60K | -10.64M | -8.22M |